Ceyoka (private) Limited Pharmaceutical Import Profile — Sri Lanka (DGFT 2022–2026)

Name: Ceyoka (private) Limited Pharmaceutical Import Records from India — 3 Products, $1.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ceyoka (private) Limited — Pharmaceutical Importer Profile (2026) | 3 Products, $1.6M Trade | TransData Nexus

Ceyoka (private) Limited

Pharmaceutical Importer · Sri Lanka · Advanced Antifungals Focus · $1.6M Total Trade · DGFT Verified

Ceyoka (private) Limited is a pharmaceutical importer based in Sri Lanka with a total trade value of $1.6M across 3 products in 3 therapeutic categories. Based on 45 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Ceyoka (private) Limited sources from 3 verified Indian suppliers, with Leben Laboratories Private Limited accounting for 95.4% of imports.

Ceyoka (private) Limited — Import Portfolio & Supplier Network

Ceyoka (private) Limited import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Ceyoka (private) Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Leben Laboratories Private Limited	$1.9M	367	95.4%
Galentic Pharma India Private Limited	$78.6K	5	3.9%
Bharat Serums And Vaccines Limited

What Formulations Does Ceyoka (private) Limited Import?

Formulation	Value	Ships
Paracetamol tablet 500 MG BP 1000's	$53.7K	2
Enderm GM cream BP 15 GM tube clobetasol gentamicin miconazole pharmaceutical products	$50.0K	1
Beclomin ointment BP 15 GM tube	$50.0K	1
Beclomin ointment BP 15 GM tube beclomethasone dipropiona+ miconazole + neomycin pharmaceutical products-	$50.0K	1
Enderm GM cream 15 GM tube clobetasol + gentamicin + miconazole pharmaceutical products-	$50.0K	1
Enderm GM cream 15 GM tube clobetasol + gentamicin + miconazole pharmaceutical products-	$50.0K	1
Griseofulvin tablet BP 500 MG 10 s x 10 x 20738 pac griseben 500 tablet pharmaceutical products	$50.0K	1
Griseofulvin tablet 500 MG BP 10's x 10 x 8928 pac griseben - 500 tablet pharmaceutical article / ods / product / item	$50.0K	1
Paracetamol tablet 500 MG BP 1000's pac kelvin tablet pharmaceutical products-	$49.9K	1
Griseofulvin tablet BP 500 MG 10's x 10 x 7940 pac griseben - 500 tablet pharmaceutical article / ods / product / item	$44.5K	1
Harmless medicines sofudac cream 15g fusidic acid cream BP	$43.1K	1
Libitus cough syrup 100 ML btl	$41.4K	1
Diclofenac sodium 50 MG tablet 20's x 10 pac adiflam tablet pharmaceutical products-	$41.4K	1
Enderm GM cream 15 GM tube clobetasol + gentamicin + miconazole pharmaceutical products-	$40.7K	1
Enderm GM cream 15 GM tube clobetasol + gentamicin + miconazole pharmaceutical products-	$39.7K	1

Ceyoka (private) Limited imports 353 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Griseofulvin	Advanced Antifungals	$890.8K	27	1.8%	5
2	Miconazole	Antifungals	$445.5K	12	2.3%	5
3	Gentamicin	Antibiotics	$300.0K	6	0.6%	16

Ceyoka (private) Limited imports 3 pharmaceutical products across 3 categories into Sri Lanka totaling $1.6M.

Ceyoka (private) Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Ceyoka (Private) Limited, established in 1985, is a diversified Sri Lankan company headquartered at 55 Negombo Road, Peliyagoda, Sri Lanka. Over the past four decades, Ceyoka has played a pivotal role in the nation's development by supplying goods and services to both public and private sectors. The company's diversified activities encompass trading, healthcare, essential oils and flavors, and commercial air conditioning.

Within the healthcare sector, Ceyoka Health is recognized as a leading supplier of pharmaceuticals, medical devices, and surgical equipment to both government and private institutions in Sri Lanka. The company has achieved industry firsts, including introducing advanced needle-free technology and offering dialysis services in collaboration with Fresenius Medical Care. (ft.lk) Additionally, Ceyoka has expanded its portfolio by becoming the exclusive distributor for Eurofarma, a prominent Brazilian pharmaceutical company, in 2015. (ft.lk)

2Distribution Network

Ceyoka's distribution network is strategically designed to ensure nationwide coverage across Sri Lanka. The company's headquarters in Peliyagoda serve as the central hub for its operations. While specific warehouse locations are not publicly disclosed, Ceyoka's extensive sales and service network facilitates efficient logistics and timely delivery of products to various regions within the country. This infrastructure supports the company's role as a key supplier of pharmaceuticals, medical devices, and other products to both government and private sector institutions.

3Industry Role

Ceyoka (Private) Limited holds a significant position in Sri Lanka's pharmaceutical supply chain as a primary wholesaler and distributor. The company imports a diverse range of pharmaceutical products, including advanced antifungals, antifungals, and antibiotics, catering to various therapeutic needs. Ceyoka Health, a division of the company, is recognized as a leading supplier of pharmaceuticals, medical devices, and surgical equipment to both government and private sector institutions in Sri Lanka. This extensive involvement underscores Ceyoka's integral role in ensuring the availability of essential healthcare products across the nation.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Ceyoka (private) Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Ceyoka's sourcing strategy exhibits a high degree of concentration, with a total import value of $1.6 million USD from India over 45 shipments, primarily sourced from three Indian suppliers:

LEBEN LABORATORIES PRIVATE LIMITED: $1.9 million USD (95.4% of shipments)
GALENTIC PHARMA INDIA PRIVATE LIMITED: $79,000 USD (3.9% of shipments)
BHARAT SERUMS AND VACCINES LIMITED: $15,000 USD (0.7% of shipments)

This concentration suggests a strategic choice to maintain strong relationships with select suppliers, potentially ensuring favorable terms and consistent product quality. However, the heavy reliance on a single supplier, LEBEN LABORATORIES PRIVATE LIMITED, which accounts for 95.4% of shipments, introduces a risk of supply chain disruption in the event of issues with this supplier. The stability of this relationship is crucial for Ceyoka's operations, and any disturbances could significantly impact the company's ability to meet market demand.

2Supply Chain Resilience

Importing Pharmaceuticals into Sri Lanka — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Sri Lanka

1Regulatory Authority & Framework

The National Medicines Regulatory Authority (NMRA) is the primary regulatory body overseeing pharmaceutical imports in Sri Lanka. The NMRA operates under the Medicines (Pricing Mechanism for Medicines) Regulations, which grant it explicit authority to impose and control prices for all medicines in the country. All pharmaceutical products imported into Sri Lanka must be registered with the NMRA and obtain approval before distribution or sale. This process ensures that imported medicines meet the country's quality, safety, and efficacy standards. (nmra.gov.lk)

2Import Licensing & GMP

Import licensing is a critical component of Sri Lanka's pharmaceutical import regulations. Applications for import licenses must be submitted to the NMRA, accompanied by necessary documentation, including evidence of previous importation and participation in tenders. As of February 2026, the NMRA has introduced new requirements for price submissions, particularly for import licenses expiring on or after 1st February 2026. Additionally, imported pharmaceutical products must comply with Good Manufacturing Practice (GMP) standards. The NMRA recognizes GMP certificates from various international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). This recognition ensures that imported medicines adhere to internationally accepted quality standards. (nmra.gov.lk)

Ceyoka (private) Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Ceyoka's product strategy focuses on importing and distributing a range of pharmaceutical products, including advanced antifungals, antifungals, and antibiotics. The company's portfolio is heavily concentrated in the advanced antifungal category, which constitutes 54.4% of its imports, followed by antifungals at 27.2%, and antibiotics at 18.3%. This focus aligns with the market demand for effective treatments in these therapeutic areas. The high import values of specific products, such as Griseofulvin ($891K) and Miconazole ($445K), indicate a strategic emphasis on these medications. The demand for these products is likely driven by the prevalence of fungal infections and the need for effective antifungal therapies in the Sri Lankan market.

2Sourcing Profile

Ceyoka's sourcing strategy is characterized by a high degree of concentration, with a significant portion of its pharmaceutical imports originating from India. The company imports finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, rather than raw Active Pharmaceutical Ingredients (APIs) or bulk drugs. This approach suggests a preference for ready-to-market products that meet the regulatory standards of Sri Lanka. The reliance on a limited number of suppliers, particularly LEBEN LABORATORIES PRIVATE LIMITED, indicates a strategic choice to maintain strong supplier relationships, though it also introduces potential risks associated with supply chain disruptions.

Frequently Asked Questions — Ceyoka (private) Limited

What products does Ceyoka (private) Limited import from India?

Ceyoka (private) Limited imports 3 pharmaceutical products across 3 categories. Top imports: Griseofulvin ($890.8K), Miconazole ($445.5K), Gentamicin ($300.0K).

Who supplies pharmaceuticals to Ceyoka (private) Limited from India?

Ceyoka (private) Limited sources from 3 verified Indian suppliers. The primary supplier is Leben Laboratories Private Limited (95.4% of imports, $1.9M).

What is Ceyoka (private) Limited's total pharmaceutical import value?

Ceyoka (private) Limited's total pharmaceutical import value from India is $1.6M, based on 45 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Ceyoka (private) Limited focus on?

Ceyoka (private) Limited imports across 3 categories. The largest: Advanced Antifungals (54.4%), Antifungals (27.2%), Antibiotics (18.3%).

Get Full Ceyoka (private) Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Ceyoka (private) Limited

Ceyoka (private) Limited — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Ceyoka (private) Limited?

What Formulations Does Ceyoka (private) Limited Import?

What Products Does Ceyoka (private) Limited Import?

Top Products by Import Value

Ceyoka (private) Limited Therapeutic Categories — 3 Specializations